1. Academic Validation
  2. Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency

Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency

  • J Clin Invest. 2017 Mar 1;127(3):912-928. doi: 10.1172/JCI89626.
Svjetlana Lovric Sara Goncalves Heon Yung Gee Babak Oskouian Honnappa Srinivas Won-Il Choi Shirlee Shril Shazia Ashraf Weizhen Tan Jia Rao Merlin Airik David Schapiro Daniela A Braun Carolin E Sadowski Eugen Widmeier Tilman Jobst-Schwan Johanna Magdalena Schmidt Vladimir Girik Guido Capitani Jung H Suh Noëlle Lachaussée Christelle Arrondel Julie Patat Olivier Gribouval Monica Furlano Olivia Boyer Alain Schmitt Vincent Vuiblet Seema Hashmi Rainer Wilcken Francois P Bernier A Micheil Innes Jillian S Parboosingh Ryan E Lamont Julian P Midgley Nicola Wright Jacek Majewski Martin Zenker Franz Schaefer Navina Kuss Johann Greil Thomas Giese Klaus Schwarz Vilain Catheline Denny Schanze Ingolf Franke Yves Sznajer Anne S Truant Brigitte Adams Julie Désir Ronald Biemann York Pei Elisabet Ars Nuria Lloberas Alvaro Madrid Vikas R Dharnidharka Anne M Connolly Marcia C Willing Megan A Cooper Richard P Lifton Matias Simons Howard Riezman Corinne Antignac Julie D Saba Friedhelm Hildebrandt
Abstract

Steroid-resistant nephrotic syndrome (SRNS) causes 15% of chronic kidney disease cases. A mutation in 1 of over 40 monogenic genes can be detected in approximately 30% of individuals with SRNS whose symptoms manifest before 25 years of age. However, in many patients, the genetic etiology remains unknown. Here, we have performed whole exome sequencing to identify recessive causes of SRNS. In 7 families with SRNS and facultative ichthyosis, adrenal insufficiency, immunodeficiency, and neurological defects, we identified 9 different recessive mutations in SGPL1, which encodes sphingosine-1-phosphate (S1P) lyase. All mutations resulted in reduced or absent SGPL1 protein and/or Enzyme activity. Overexpression of cDNA representing SGPL1 mutations resulted in subcellular mislocalization of SGPL1. Furthermore, expression of WT human SGPL1 rescued growth of SGPL1-deficient dpl1Δ yeast strains, whereas expression of disease-associated variants did not. Immunofluorescence revealed SGPL1 expression in mouse podocytes and mesangial cells. Knockdown of Sgpl1 in rat mesangial cells inhibited cell migration, which was partially rescued by VPC23109, an S1P receptor antagonist. In Drosophila, Sply mutants, which lack SGPL1, displayed a phenotype reminiscent of nephrotic syndrome in nephrocytes. WT Sply, but not the disease-associated variants, rescued this phenotype. Together, these results indicate that SGPL1 mutations cause a syndromic form of SRNS.

Figures